Prot#EDP 305-201: A Phase 2 Dose Ranging, Randomized, Double Blind, PlaceBo-controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Primary Biliary Cholangitis(PBC) with or without Inadequate Respons

Project: Research project

Project Details

StatusActive
Effective start/end date8/2/188/2/21

Funding

  • PRA Health Sciences (Prot# EDP 305-201)
  • Enanta Pharmaceuticals, Inc. (Prot# EDP 305-201)